The COVID‐19 pandemic has affected cancer care worldwide. This study aimed to estimate
the long‐term impacts of cancer care disruptions on cancer mortality in Canada using a …

Background Changes in the management of patients with cancer and delays in treatment
delivery during the COVID-19 pandemic may impact the use of hospital resources and …

Objectives To estimate the impact of the COVID-19 pandemic on cancer care services and
overall (direct and indirect) excess deaths in people with cancer. Methods We employed …

Background Since a national lockdown was introduced across the UK in March, 2020, in
response to the COVID-19 pandemic, cancer screening has been suspended, routine …

Introduction Delays in cancer diagnosis arose from the commencement of non-
pharmaceutical interventions (NPI) introduced in the UK in March 2020 in response to the …

Background The COVID-19 pandemic has strained health system capacity worldwide due to
a surge of hospital admissions, while mitigation measures have simultaneously reduced …

Background During the COVID-19 lockdown, referrals via the 2-week-wait urgent pathway
for suspected cancer in England, UK, are reported to have decreased by up to 84%. We …

Background Long-term projections of cancer incidence and mortality estimate the future
burden of cancer in a population, and can be of great use in informing the planning of health …

Patients with cancer, both active and previously treated, may be at higher risk of severe
outcomes from COVID-19 compared to the general population (Dai et al., 2020; Bakouny et …

Aim Decreased cancer incidence and reported changes to clinical management indicate
that the COVID‐19 pandemic has delayed cancer diagnosis and treatment. This study aimed …